<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Neuroscience</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/246CA4D5-C06A-468A-A139-15AC01BB1CD6"><gtr:id>246CA4D5-C06A-468A-A139-15AC01BB1CD6</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Bray</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802166"><gtr:id>152E33EB-57D9-4175-9981-302D2551DBDD</gtr:id><gtr:title>Molecular Mechanisms in Schizophrenia Susceptibility</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0802166</gtr:grantReference><gtr:abstractText>Schizophrenia is a severe mental illness which affects about 1 in every 100 people in Britain. Currently, little is known about how the brain is altered in schizophrenia. However, scientists have recently found genes that increase the chances of developing the illness. Researchers at the Institute of Psychiatry, Kings College London, are investigating how changes in these genes lead to changes in the human brain. They will first test to see if changes in these genes lead to differences in the level of the gene products in brain. They will then alter the level of these gene products in cells taken from the human brain to see how it affects these cells. This research will provide important new understanding of how changes in the brain lead to schizophrenia. This will help scientists develop new treatments for this devastating illness.</gtr:abstractText><gtr:technicalSummary>Schizophrenia is a common and severe neuropsychiatric disorder. Neurobiological research has thus far provided only broad clues to aetiology and pathophysiology. The recent identification of susceptibility genes for schizophrenia provides an unparalleled starting point for unravelling the pathogenic mechanisms commonly involved in the disorder. It is widely hypothesised that variants within these genes increase risk for schizophrenia by altering the expression of the molecules they encode. This research will specifically test this hypothesis through highly stringent measures of relative allelic expression in human brain tissue. It will investigate which transcripts of these genes are affected by schizophrenia susceptibility variants and in which brain regions these effects are largest. These effects on gene expression will then be modelled in human neural cell lines using RNA interference. The cellular transcriptomic consequences of these perturbations will be assessed using whole genome expression arrays, in order to shed light on the molecular pathways and cellular processes by which they lead to increased susceptibility to schizophrenia. This research will significantly advance our understanding of schizophrenia disease mechanisms, with the potential of identifying novel therapeutic targets for the disorder.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>469855</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>8750</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Psychiatry Research Trust</gtr:department><gtr:description>Project grant/Psychiatry Research Trust</gtr:description><gtr:end>2013-05-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>51DA509B-C8A7-4C73-B535-70A4DD6C6BD6</gtr:id><gtr:outcomeId>ngTxUdWkf680</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have used RNA interference to alter the expression of identified schizophrenia susceptibility genes in human neural progenitor cell lines. We have extracted RNA and protein from these cells and performed genome-wide expression profiling..</gtr:description><gtr:id>F3D860F2-F29E-443B-9A41-306F56D72132</gtr:id><gtr:impact>Genome-wide expression data resulting from knockdown of one susceptibility gene have already been released in association with a publication (Hill et al, HMG 2012). The molecular susceptibility pathway identified has been used by at least two other groups (O'Donohoe, Trinity College Dublin; Riley, Virginia Commonwealth University) in relation to neuroimaging measures and risk for schizophrenia. Manuscripts relating to two other genes have been submitted and genome-wide expression data will be released on publication.</gtr:impact><gtr:outcomeId>M7osyCXRWXe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human neural cell lines with knockdown of schizophrenia susceptibility genes</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>RNA has been extracted from at least 6 discrete brain regions from each of 20 subjects.</gtr:description><gtr:id>BBACEC9E-216C-439D-A854-FB1C25384654</gtr:id><gtr:impact>Using this material, we have shown that cis-effects on gene expression can differ between brain regions. This has formed the basis of a published paper in Human Molecular Genetics (Buonocore et al, 2010). We will continue to use this resource to investigate where in the brain genetic variants associated with schizophrenia are active.</gtr:impact><gtr:outcomeId>eiM8zfi2eMP</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Human brain RNA collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4C898F74-4D58-4A95-A927-AF6554B37F2A</gtr:id><gtr:title>Knockdown of the schizophrenia susceptibility genealters gene expression and proliferation of progenitor cells from the developing human neocortex.</gtr:title><gtr:parentPublicationTitle>Journal of psychiatry &amp; neuroscience : JPN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1124fe16377801b276304519627d17a"><gtr:id>c1124fe16377801b276304519627d17a</gtr:id><gtr:otherNames>Hill MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1180-4882</gtr:issn><gtr:outcomeId>582203e31e5c46.18046528</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB810F6-DCB2-41AA-A12E-B850E3971D75</gtr:id><gtr:title>Knockdown of the psychosis susceptibility gene ZNF804A alters expression of genes involved in cell adhesion.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1124fe16377801b276304519627d17a"><gtr:id>c1124fe16377801b276304519627d17a</gtr:id><gtr:otherNames>Hill MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>i5PDMEy42cp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0450AE8-1017-4B45-B620-CBAD95860EB4</gtr:id><gtr:title>Effects of cis-regulatory variation differ across regions of the adult human brain.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8029b5fa71b5ae4810ff87b504939315"><gtr:id>8029b5fa71b5ae4810ff87b504939315</gtr:id><gtr:otherNames>Buonocore F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>PmygedUvadr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67F30E81-F33E-4CA7-9D4A-00DC39C75960</gtr:id><gtr:title>The neurobiology of schizophrenia: new leads and avenues for treatment.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/135e9ad2f70b3d6a351d48ef72de104c"><gtr:id>135e9ad2f70b3d6a351d48ef72de104c</gtr:id><gtr:otherNames>Bray NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>CcektfcQHNg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61E351C0-8835-4AFE-B09D-637AA3F98F9E</gtr:id><gtr:title>Genome-wide significant schizophrenia risk variation on chromosome 10q24 is associated with altered cis-regulation of BORCS7, AS3MT, and NT5C2 in the human brain.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d182f9c5c19fb926bfa186a131dc784"><gtr:id>7d182f9c5c19fb926bfa186a131dc784</gtr:id><gtr:otherNames>Duarte RRR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>582203e2ce2695.97860409</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FBEE54F-BAF4-40D7-B5BA-9FD02387D823</gtr:id><gtr:title>Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development.</gtr:title><gtr:parentPublicationTitle>The American journal of psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1124fe16377801b276304519627d17a"><gtr:id>c1124fe16377801b276304519627d17a</gtr:id><gtr:otherNames>Hill MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0002-953X</gtr:issn><gtr:outcomeId>kEkTrTnSAWU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>998C9E05-E84B-48C5-AFCC-24279CD91A20</gtr:id><gtr:title>Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells.</gtr:title><gtr:parentPublicationTitle>Schizophrenia research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1124fe16377801b276304519627d17a"><gtr:id>c1124fe16377801b276304519627d17a</gtr:id><gtr:otherNames>Hill MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0920-9964</gtr:issn><gtr:outcomeId>5450d7fb92a734.10668339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E79B0606-5190-464B-86FC-EE5027DCE273</gtr:id><gtr:title>Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1124fe16377801b276304519627d17a"><gtr:id>c1124fe16377801b276304519627d17a</gtr:id><gtr:otherNames>Hill MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>jyV6SjEmkoB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C434644C-916A-4898-AF54-B5D08DCAEEF0</gtr:id><gtr:title>Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure.</gtr:title><gtr:parentPublicationTitle>Biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5bec453827a3df612b65b863e41e0e0e"><gtr:id>5bec453827a3df612b65b863e41e0e0e</gtr:id><gtr:otherNames>Deans PJM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0006-3223</gtr:issn><gtr:outcomeId>58a568b6981dd2.01128699</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802166</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>